Zevra Therapeutics, Inc.
ZVRA
$8.00
-$0.21-2.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 223.50% | -9.88% | -22.24% | 81.44% | -6.56% |
| Total Receivables | 44.77% | 20.06% | 34.90% | -12.93% | 7.73% |
| Inventory | -56.70% | 29.90% | -- | -- | -- |
| Prepaid Expenses | 15.56% | -7.06% | 78.03% | -15.26% | 43.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 177.47% | -5.18% | -13.49% | 63.31% | -3.18% |
|
|
|||||
| Total Current Assets | 177.47% | -5.18% | -13.49% | 63.31% | -3.18% |
| Net Property, Plant & Equipment | 1.80% | 103.16% | -29.01% | -10.20% | -10.78% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -89.53% | -2.34% | -2.29% | 6.73% | -2.28% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -90.81% | -4.17% | 22.82% | -16.30% | -22.09% |
| Total Assets | 48.39% | -3.04% | -7.01% | 32.65% | -4.54% |
|
|
|||||
| Total Accounts Payable | -11.09% | 36.28% | -46.55% | 19.62% | -10.24% |
| Total Accrued Expenses | 8.36% | -70.25% | 103.23% | 26.29% | 52.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.87% | 40.24% | -22.22% | -9.40% | 2.23% |
| Total Finance Division Other Current Liabilities | 101.88% | 6.28% | 244.09% | -64.68% | 26.04% |
| Total Other Current Liabilities | 101.88% | 6.28% | 244.09% | -64.68% | 26.04% |
| Total Current Liabilities | 6.88% | -20.81% | -1.21% | 13.24% | 1.81% |
|
|
|||||
| Total Current Liabilities | 6.88% | -20.81% | -1.21% | 13.24% | 1.81% |
| Long-Term Debt | 1.00% | 0.98% | 1.02% | 0.99% | 35.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.55% | 211.29% | -22.98% | -11.21% | -22.84% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.51% | -2.38% | 59.50% | 23.46% | -21.64% |
| Total Liabilities | 5.59% | -4.89% | 13.70% | 8.80% | 9.24% |
|
|
|||||
| Common Stock & APIC | 0.69% | 0.93% | 0.89% | 14.82% | 0.69% |
| Retained Earnings | 14.69% | -0.61% | -7.61% | -7.61% | -4.79% |
| Treasury Stock & Other | -21.20% | -6.89% | 6.72% | -5.07% | 2.58% |
| Total Common Equity | 185.77% | 3.42% | -43.15% | 114.82% | -33.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 185.77% | 3.42% | -43.15% | 114.82% | -33.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 185.77% | 3.42% | -43.15% | 114.82% | -33.47% |
|
|
|||||